(based on 1,290 customer ratings)

Course provided by LabCE.

See more courses in: Clinical Chemistry / Urinalysis / Toxicology

Continuing Education Credits

Florida Board of Clinical Laboratory Personnel Credit Hours - General (Clinical Chemistry/UA/Toxicology): 2 hour(s)
Course number 20-778854, approved through 9/1/2022


  • Define diabetes and differentiate between type 1 and type 2 diabetes.
  • Discuss gestational diabetes and other causes of diabetes.
  • Explain the role of the clinical laboratory in the diagnosis and monitoring diabetes.
  • Discuss the signs and symptoms of diabetes.
  • List the common ways to prevent, manage, and treat diabetes.
  • Identify clinical and laboratory criteria that indicates increased risk for diabetes.
  • List the current assays used to monitor diabetic patients.
  • Explain the recommendations made by the American Diabetes Association in regards to diagnosis and monitoring of diabetes.

Customer Ratings

(based on 1,290 customer ratings)

Course Outline

  • Overview of Diabetes: Definition and Facts
      • Organizations and Agencies
      • Diabetes: Definition
      • Diabetes: Facts
      • Diabetes: A Metabolic Disorder
  • Blood Glucose and Hormonal Control
      • Blood Glucose and Hormonal Control
      • Blood Glucose and Hormonal Control (continued)
      • Blood Glucose and Hormonal Control (continued)
  • Classification of Diabetes
      • The Four Clinical Classes of Diabetes
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Type 2 Diabetes: Prediabetes
      • When is Diabetes Classified as Type 1 or Type 2?
      • Gestational Diabetes (GDM)
      • Diabetes Due to Other Causes
  • Risk, Complications, and Management of Diabetes
      • Signs and Symptoms of Diabetes
      • Risk Factors and Complications of Diabetes
      • Treatment and Management of Diabetes
      • Treatment and Management of Diabetes (continued)
  • Screening for Diabetes and Updated ADA Guidelines
      • American Diabetes Association (ADA) Guidelines: 2018 Update
      • ADA Guidelines: 2018 Update (continued)
      • ADA Guidelines: Criteria for Diabetes Diagnosis
      • ADA Testing Guidelines for Type 2 Diabetes and Prediabetes in Asymptomatic Adults
      • ADA Guidelines: Categories of Increased Risk for Diabetes (Prediabetes)
      • ADA Targets for Monitoring Glycemic Control (Hb A1c)
  • Laboratory Assays in Evaluating Diabetic Patients
      • Clinical Laboratory Testing
      • Blood Glucose Testing
      • Whole Blood Glucose Testing
      • Urine Glucose
      • Urinary Albumin and Testing for Microalbuminuria
      • Testing for Ketones
      • Insulin and C-Peptide
      • Insulin Antibodies
      • Glycated Proteins and Hb A1C
      • Hb A1C versus Blood Glucose Measurement
      • Fructosamine
      • Oral Glucose Tolerance Test (OGTT)
      • Continuous Glucose Monitoring (CGM)
  • Estimated Average Glucose (eAG)
      • Estimated Average Glucose
      • The Relationship Between Hb A1C and Estimated Average Glucose (eAG)
  • Case Studies in Diabetes
      • Case Studies
      • Case A
      • Case B
      • Case C
  • The Laboratory's Role in Diabetes
      • The Laboratory's Role in Diagnosis and Monitoring of Diabetes
  • References
      • References
How to Subscribe
Single online course$20
Add to cart
  • Order for instant access through any computer, any browser.
  • No shipping, faxing, or waiting for certificates.
  • Print or save your certificate of completion as soon as you've completed the course.
  • You'll have 90 days to complete your purchased courses.
Course provided by LabCE.

ASCLS CE's design and platform are provided by MediaLab, Inc.